These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

855 related articles for article (PubMed ID: 31106371)

  • 21. SliceIt: A genome-wide resource and visualization tool to design CRISPR/Cas9 screens for editing protein-RNA interaction sites in the human genome.
    Vemuri S; Srivastava R; Mir Q; Hashemikhabir S; Dong XC; Janga SC
    Methods; 2020 Jun; 178():104-113. PubMed ID: 31494246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guide RNAs: A Glimpse at the Sequences that Drive CRISPR-Cas Systems.
    Briner AE; Barrangou R
    Cold Spring Harb Protoc; 2016 Jul; 2016(7):. PubMed ID: 27371605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Developing Rice Mutants Using CRISPR/Cas9-Based Genome Editing Technology.
    Xu K; Li Y
    Methods Mol Biol; 2022; 2400():11-19. PubMed ID: 34905186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genome editing using the endogenous type I CRISPR-Cas system in
    Hidalgo-Cantabrana C; Goh YJ; Pan M; Sanozky-Dawes R; Barrangou R
    Proc Natl Acad Sci U S A; 2019 Aug; 116(32):15774-15783. PubMed ID: 31341082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design of a generic CRISPR-Cas9 approach using the same sgRNA to perform gene editing at distinct loci.
    Najah S; Saulnier C; Pernodet JL; Bury-Moné S
    BMC Biotechnol; 2019 Mar; 19(1):18. PubMed ID: 30894153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Programmable CRISPR-Cas Repression, Activation, and Computation with Sequence-Independent Targets and Triggers.
    Jin M; Garreau de Loubresse N; Kim Y; Kim J; Yin P
    ACS Synth Biol; 2019 Jul; 8(7):1583-1589. PubMed ID: 31290648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficient Cas9 multiplex editing using unspaced sgRNA arrays engineering in a Potato virus X vector.
    Uranga M; Aragonés V; Selma S; Vázquez-Vilar M; Orzáez D; Daròs JA
    Plant J; 2021 Apr; 106(2):555-565. PubMed ID: 33484202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of the CRISPR/Cas system for genome editing in microalgae.
    Zhang YT; Jiang JY; Shi TQ; Sun XM; Zhao QY; Huang H; Ren LJ
    Appl Microbiol Biotechnol; 2019 Apr; 103(8):3239-3248. PubMed ID: 30877356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploration of Microbial Diversity to Discover Novel Molecular Technologies.
    Zhang F
    Keio J Med; 2019; 68(1):26. PubMed ID: 30905885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Single Transcript CRISPR-Cas9 System for Multiplex Genome Editing in Plants.
    Tang X; Zhong Z; Ren Q; Liu B; Zhang Y
    Methods Mol Biol; 2019; 1917():75-82. PubMed ID: 30610629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CRISPR-ERA: A Webserver for Guide RNA Design of Gene Editing and Regulation.
    Liu H; Wang X
    Methods Mol Biol; 2021; 2189():65-69. PubMed ID: 33180293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CRISPcut: A novel tool for designing optimal sgRNAs for CRISPR/Cas9 based experiments in human cells.
    Dhanjal JK; Radhakrishnan N; Sundar D
    Genomics; 2019 Jul; 111(4):560-566. PubMed ID: 29605634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simplified CRISPR-Mediated DNA Editing in Multicellular Eukaryotes.
    Kumar R; Tiwari K; Saudagar P
    Methods Mol Biol; 2023; 2575():241-260. PubMed ID: 36301478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Smart Strategies for Precise Delivery of CRISPR/Cas9 in Genome Editing.
    Hasanzadeh A; Noori H; Jahandideh A; Haeri Moghaddam N; Kamrani Mousavi SM; Nourizadeh H; Saeedi S; Karimi M; Hamblin MR
    ACS Appl Bio Mater; 2022 Feb; 5(2):413-437. PubMed ID: 35040621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential pitfalls of CRISPR/Cas9-mediated genome editing.
    Peng R; Lin G; Li J
    FEBS J; 2016 Apr; 283(7):1218-31. PubMed ID: 26535798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CRISPR/Cas9 in Genome Editing and Beyond.
    Wang H; La Russa M; Qi LS
    Annu Rev Biochem; 2016 Jun; 85():227-64. PubMed ID: 27145843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Harnessing the Potential of CRISPR/Cas in Atherosclerosis: Disease Modeling and Therapeutic Applications.
    Siew WS; Tang YQ; Kong CK; Goh BH; Zacchigna S; Dua K; Chellappan DK; Duangjai A; Saokaew S; Phisalprapa P; Yap WH
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeted genome editing in human cells using CRISPR/Cas nucleases and truncated guide RNAs.
    Fu Y; Reyon D; Joung JK
    Methods Enzymol; 2014; 546():21-45. PubMed ID: 25398334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genome Editing in Potato with CRISPR/Cas9.
    Nadakuduti SS; Starker CG; Voytas DF; Buell CR; Douches DS
    Methods Mol Biol; 2019; 1917():183-201. PubMed ID: 30610637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genome-scale CRISPR pooled screens.
    Sanjana NE
    Anal Biochem; 2017 Sep; 532():95-99. PubMed ID: 27261176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.